Skip to main content
NRIXHealthcare

Nurix Therapeutics Inc (NRIX) Insider Trading

In the last 90 days, 4 Nurix Therapeutics Inc (NRIX) insiders reported no open-market purchases and 9 sales totaling $1,592,421. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Gwenn HansenChief Scientific OfficerSale1,452$25.00$36,300
Oct 14, 2026Julia P GregoryCorporate insiderSale22,583$23.40$528,528
Oct 2, 2026Christine RingChief Legal OfficerSale5,786$23.19$134,149
Sep 2, 2026Christine RingChief Legal OfficerSale5,787$25.76$149,073
Sep 1, 2026Gwenn HansenChief Scientific OfficerSale1,452$25.47$36,982
Aug 5, 2026Gwenn HansenChief Scientific OfficerSale4,356$25.00$108,900
Aug 4, 2026Houte Hans vanChief Financial OfficerSale4,761$24.36$115,989
Aug 4, 2026Gwenn HansenChief Scientific OfficerSale4,111$24.36$100,141
Aug 3, 2026Christine RingChief Legal OfficerSale16,589$23.05$382,358
Jul 30, 2026Houte Hans vanChief Financial OfficerSale2,845$23.38$66,524

Common questions

NRIX insider trading FAQ

Are NRIX insiders buying or selling?
Over the last 90 days, NRIX insiders were net sellers, reporting $0.00 of open-market purchases and $1,592,421 of sales.
When was the last NRIX insider purchase?
No open-market insider purchase of Nurix Therapeutics Inc stock was reported in the last 90 days.
Where does NRIX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Nurix Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.